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We have previously reported that the tetrahydrotetra-
methylnaphthalene (TMN) derivative TMNAA is a
selective inhibitor of Adult T-cell Leukemia (ATL) and
HTLV-1-infected cell lines but not non-ATL cell lines
and peripheral blood mononuclear cells (PBMCs). In
this study, several derivatives of TMNAA were synthe-
sized and examined for their inhibitory effect on the
proliferation of various T cell lines and PBMCs by a tet-
razolium dye method. The modes of cell death and cell
cycle arrest were also examined by flow cytometry.
Among the compounds, MN417 having a tetrahydrote-
tramethylbenzophenanthridinone structure was found to
be a more potent inhibitor of ATL and HTLV-1-
infected cell lines than TMNAA. The 50% inhibitory
concentrations (IC50s) of MN417 and TMNAA for
ATL and HTLV-1-infected cell lines, including S1T and
MT-2 cells, were 0.59-6.6 and 2.2-34.2 μM, respectively,
depending on the test cell lines. In contrast, the IC50s of
MN417 and TMNAA for non-ATL cell lines, such as
MOLT-4 and CEM cells, were > 20 and > 100 µM,
respectively. The elimination of the TMN moiety from
MN417 failed to inhibit the proliferation of ATL and
HTLV-1-infected cell lines, suggesting that the TMN
moiety was required for the selective inhibition of these
cell lines. Furthermore, both MN417 and TMNAA hardly
induced apoptosis and cell cycle arrest. Thus, although
the target molecule for inhibition of ATL cells remains to
be elucidated, the compounds may have potential as
novel and selective chemotherapeutic agents ATL.
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